NCT06176170View on ClinicalTrials.gov

VividWhite Glaucoma Implant (VW-51) Pivotal Study

NARecruitingINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

December 12, 2023

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Glaucoma
Interventions
DEVICE

VividWhite Glaucoma Implant (VW-51)

Subconjunctival surgical implantation of the VW-51 implant in the study eye.

Trial Locations (6)

2000

RECRUITING

Sydney Eye Hospital, Sydney

3002

RECRUITING

Cerulea Clinical Trials, Centre for Eye Research Australia, East Melbourne

3065

RECRUITING

Melbourne Eye Specialists, Fitzroy

3109

RECRUITING

Cataract & Eye Surgery Centre, Doncaster East

3133

RECRUITING

Eye Surgery Associates, Vermont South

5042

RECRUITING

Flinders Medical Centre, Bedford Park

All Listed Sponsors
lead

VividWhite Pty Ltd

INDUSTRY